Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1641 - 1648 of 11617 results
California Legislative Update Part I: New Requirements for Licensed Health Care Professionals
November 11, 2022| Blog| Viewpoint
The Government’s Long Game for Investigating COVID-19 Relief Fraud
November 11, 2022| News
Stanford Prof Pays Investors In Defunct Biotech Nuredis $29m
November 11, 2022| News
Smoked Out: How Those In The Cannabis Industry May Finally Gain Bankruptcy Protection
November 10, 2022| Blog| Viewpoint
Consumer Suits Against Gerber Baby Foods Dismissed
November 10, 2022| Blog| Viewpoint
6 Tips For Completing A SPAC Merger In A Harsh Environment
November 10, 2022| News
Why A 76-Year-Old Top Court Case Could Undo 'Varsity Blues'
November 10, 2022| News
Will GCs Use Pay Transparency Laws For Candid Approach?
November 10, 2022| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.